Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In KRW
Address
8, Chungjeong-ro
Seoul,
Korea (the Republic of)
Phone
82 2 2194 0300
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2276
First IPO Date
December 06, 2013
| Name | Title | Pay | Year Born |
| Young-Joo Kim | President, Chief Executive Officer & Chairman | 710M | N/A |
| Dong-ha Lee | Finance Manager & Director | 0 | N/A |
Chong Kun Dang Pharmaceutical Corp. develops, promotes, and distributes a comprehensive array of medical and health-related goods. The company operates extensively, catering to the South Korean domestic market and extending its reach internationally through exports. Its offerings encompass critical prescription drugs, such as treatments for high blood pressure, high cholesterol, and diabetes. Additionally, it provides popular over-the-counter remedies like Penzal, Prefemine, and Modcol, alongside various consumer health commodities including insecticides and hair dyes. A significant part of its portfolio also includes health supplements aimed at disease prevention. Established in 1941, Chong Kun Dang Pharmaceutical Corp. maintains its principal office in Seoul, South Korea.